Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Luño J[au]:

Fabry Nephropathy: An Evidence-Based Narrative Review. Del Pino M et al. Kidney Blood Press Res. (2018)

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study). Goicoechea M et al. Cardiovasc Drugs Ther. (2018)

Lesinurad: what the nephrologist should know. Sanchez-Niño MD et al. Clin Kidney J. (2017)

Search results

Items: 1 to 50 of 133

1.

Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists.

Verdalles U, Goicoechea M, García de Vinuesa S, Torres E, Hernández A, Verde E, Pérez de José A, Luño J.

Nefrologia. 2019 Aug 23. pii: S0211-6995(19)30122-5. doi: 10.1016/j.nefro.2019.04.012. [Epub ahead of print] English, Spanish.

2.

Middle molecule elimination in expanded haemodialysis: only convective transport?

Macías N, Vega A, Abad S, Aragoncillo I, García-Prieto AM, Santos A, Torres E, Luño J.

Clin Kidney J. 2018 Dec 15;12(3):447-455. doi: 10.1093/ckj/sfy097. eCollection 2019 Jun.

3.

Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.

Barbieri D, Goicoechea M, Sánchez-Niño MD, Ortiz A, Verde E, Verdalles U, Pérez de José A, Delgado A, Hurtado E, Sánchez-Cámara L, Lopez-Lazareno N, García-Prieto A, Luño J.

Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.

4.

Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals.

Barbieri D, García-Prieto A, Torres E, Verde E, Goicoechea M, Luño J.

Clin Kidney J. 2018 Jul 9;12(3):362-364. doi: 10.1093/ckj/sfy055. eCollection 2019 Jun.

5.

Body composition infuences the elimination of protein-bound uremic toxins in online hemodiafiltration.

Macías N, Abad S, Aragoncillo I, Hernández A, Torres E, Santos A, López Gómez JM, Luño J, Vega A.

Nefrologia. 2019 Jul - Aug;39(4):434-436. doi: 10.1016/j.nefro.2018.09.004. Epub 2019 Apr 10. English, Spanish. No abstract available.

6.

Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial.

de Morales AM, Goicoechea M, Verde E, Carbayo J, Barbieri D, Delgado A, Verdalles U, de Jose AP, Luño J.

J Nephrol. 2019 Aug;32(4):581-587. doi: 10.1007/s40620-019-00607-0. Epub 2019 Apr 4.

PMID:
30949987
7.

Rationale and design of the PHYSICALFAV trial: a randomized controlled trial to evaluate the effect of preoperative isometric exercise on vascular calibre and maturation of autologous arteriovenous fistulas.

Aragoncillo I, Ligero JM, Hevia C, Morales AL, Amézquita Y, Cervera T, Vega A, Abad S, Macías N, Luño J.

Clin Kidney J. 2018 Dec;11(6):841-845. doi: 10.1093/ckj/sfy046. Epub 2018 Jun 22.

8.

High convective volumes are associated with improvement in metabolic profile in diabetic patients on online haemodiafiltration.

Macías N, Abad S, Vega A, Cedeño S, Santos A, Verdalles Ú, Linares T, Aragoncillo I, Galán I, García-Prieto A, Luño J, López Gómez JM.

Nefrologia. 2019 Mar - Apr;39(2):168-176. doi: 10.1016/j.nefro.2018.08.005. Epub 2018 Nov 19. English, Spanish.

9.

Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration.

García-Prieto A, Vega A, Linares T, Abad S, Macías N, Aragoncillo I, Torres E, Hernández A, Barbieri D, Luño J.

Clin Kidney J. 2018 Oct;11(5):742-746. doi: 10.1093/ckj/sfy004. Epub 2018 Feb 26.

10.

Atypical haemolytic uremic syndrome: when multiple etiologies meet.

Barbieri D, García-Prieto A, Verde E, Goicoechea M, Luño J.

Int Urol Nephrol. 2018 Nov;50(11):2109-2110. doi: 10.1007/s11255-018-1980-0. Epub 2018 Sep 24. No abstract available.

PMID:
30251008
11.

Returning to haemodialysis after kidney allograft failure: a survival study with propensity score matching.

Varas J, Pérez-Sáez MJ, Ramos R, Merello JI, de Francisco ALM, Luño J, Praga M, Aljama P, Pascual J; Optimizing Results in Dialysis (ORD) group.

Nephrol Dial Transplant. 2019 Apr 1;34(4):667-672. doi: 10.1093/ndt/gfy215.

PMID:
30053152
12.

Impact of the application of the JNC 8 and KDIGO-2013 guidelines on hypertension and lipid control in a Nephrology outpatient clinic.

Galán I, Verdalles Ú, García de Vinuesa M, Quiroga B, Goicoechea M, Pérez A, Verde E, Luño J.

Nefrologia. 2018 Jul - Aug;38(4):379-385. doi: 10.1016/j.nefro.2017.10.003. English, Spanish.

13.

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).

Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J.

Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1.

PMID:
29943364
14.

Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease.

Vega A, Abad S, Macías N, Aragoncillo I, García-Prieto A, Linares T, Torres E, Hernández A, Luño J.

Clin Kidney J. 2018 Jun;11(3):372-376. doi: 10.1093/ckj/sfy018. Epub 2018 Mar 28.

15.

Fabry Nephropathy: An Evidence-Based Narrative Review.

Del Pino M, Andrés A, Bernabéu AÁ, de Juan-Rivera J, Fernández E, de Dios García Díaz J, Hernández D, Luño J, Fernández IM, Paniagua J, Posada de la Paz M, Rodríguez-Pérez JC, Santamaría R, Torra R, Ambros JT, Vidau P, Torregrosa JV.

Kidney Blood Press Res. 2018;43(2):406-421. doi: 10.1159/000488121. Epub 2018 Mar 16. Review.

16.

Impact of anticoagulation and platelet antiaggregation on anaemia and haemorragic events in patients with chronic kidney disease stages 3 and 4.

García-Prieto A, Goicoechea M, Linares T, Panizo N, García de Vinuesa MS, Verdalles Ú, Verde E, Pérez de José A, Luño J.

Med Clin (Barc). 2018 Dec 21;151(12):476-480. doi: 10.1016/j.medcli.2018.01.021. Epub 2018 Mar 2. English, Spanish.

PMID:
29503026
17.

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study.

Luño J, Varas J, Ramos R, Merello I, Aljama P, MartinMalo A, Pascual J, Praga M; ORD Group.

Kidney Int Rep. 2017 Mar 7;2(4):665-675. doi: 10.1016/j.ekir.2017.03.001. eCollection 2017 Jul.

18.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.

Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J.

Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24.

PMID:
28987723
19.

Lesinurad: what the nephrologist should know.

Sanchez-Niño MD, Zheng-Lin B, Valiño-Rivas L, Sanz AB, Ramos AM, Luño J, Goicoechea M, Ortiz A.

Clin Kidney J. 2017 Oct;10(5):679-687. doi: 10.1093/ckj/sfx036. Epub 2017 May 26.

20.

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass.

Galán I, Goicoechea M, Quiroga B, Macías N, Santos A, García de Vinuesa MS, Verdalles Ú, Cedeño S, Verde E, Pérez de José A, García A, Luño J.

Nefrologia. 2018 Jan - Feb;38(1):73-78. doi: 10.1016/j.nefro.2017.04.006. Epub 2017 Aug 30. English, Spanish.

21.

Cardiovascular risk prediction in chronic kidney disease patients.

Cedeño Mora S, Goicoechea M, Torres E, Verdalles Ú, Pérez de José A, Verde E, García de Vinuesa S, Luño J.

Nefrologia. 2017 May - Jun;37(3):293-300. doi: 10.1016/j.nefro.2016.10.002. Epub 2017 May 8. English, Spanish.

22.

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients.

Abad S, Vega A, Rincón D, Hernández E, Mérida E, Macías N, Muñoz R, Milla M, Luño J, López-Gómez JM.

Nefrologia. 2017 Mar - Apr;37(2):158-163. doi: 10.1016/j.nefro.2016.10.003. Epub 2016 Nov 30. English, Spanish.

23.

New microorganism in catheter-related bacteremia?

Torres Aguilera E, Verde Moreno E, Muñoz P, Valerio M, Luño J.

Nefrologia. 2017 Jan - Feb;37(1):98-100. doi: 10.1016/j.nefro.2016.09.002. Epub 2016 Oct 13. English, Spanish. No abstract available.

24.

Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M, García-Prieto A, Torres E, Reque J, Luño J.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217. Epub 2016 Oct 3.

25.

Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.

Verdalles Ú, Goicoechea M, Garcia de Vinuesa S, Quiroga B, Galan I, Verde E, Perez de Jose A, Luño J.

Nefrologia. 2016 Sep - Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18. English, Spanish.

26.

The effect of some medications given to CKD patients on vitamin D levels.

Yuste C, Quiroga B, de Vinuesa SG, Goicoechea MA, Barraca D, Verdalles U, Luño J.

Nefrologia. 2015;35(2):150-6. doi: 10.1016/j.nefro.2015.05.016. Epub 2015 Jun 23.

27.

Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?

Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.

Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.

PMID:
25818266
28.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.

Quiroga B, Galán I, García de Vinuesa S, Goicoechea M, Verdalles Ú, Luño J.

Nephrol Dial Transplant. 2015 May;30(5):801-6. doi: 10.1093/ndt/gfv059. Epub 2015 Mar 9.

PMID:
25753805
29.

Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.

Am J Kidney Dis. 2015 Apr;65(4):543-9. doi: 10.1053/j.ajkd.2014.11.016. Epub 2015 Jan 13.

PMID:
25595565
30.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

31.

Combined angiotensin inhibition in diabetic nephropathy.

Quiroga B, Fernández Juárez G, Luño J.

N Engl J Med. 2014 Feb 20;370(8):777. doi: 10.1056/NEJMc1315504. No abstract available.

PMID:
24552329
32.

Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection.

Bouza E, Rojas L, Guembe M, Marín M, Anaya F, Luño J, López JM, Muñoz P; COCADI Study Group.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):316-9. doi: 10.1016/j.diagmicrobio.2013.12.008. Epub 2013 Dec 17.

PMID:
24428979
33.

Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease.

Vega A, García de Vinuesa S, Goicoechea M, Verdalles U, Martínez-Pueyo ML, Chacón A, Quiroga B, Luño J.

Int Urol Nephrol. 2014 Jun;46(6):1161-7. doi: 10.1007/s11255-013-0607-8. Epub 2013 Nov 22.

PMID:
24265040
34.

Compliance with mineral metabolism targets in haemodialysis patients: moving backwards?

Palomares I, Ramos R, Martin-Malo A, Merello JI, Praga M, Luño J, de Francisco AL; ORD Group.

Blood Purif. 2013;36(2):122-31. doi: 10.1159/000353418. Epub 2013 Nov 5.

PMID:
24217176
35.

Urate reduction and renal preservation: what is the evidence?

Macías N, Goicoechea M, de Vinuesa MS, Verdalles U, Luño J.

Curr Rheumatol Rep. 2013 Dec;15(12):386. doi: 10.1007/s11926-013-0386-3. Review.

PMID:
24203097
36.

Type of vascular access and survival among very elderly hemodialysis patients.

Praga M, Merello JI, Palomares I, Bayh I, Marcelli D, Aljama P, Luño J.

Nephron Clin Pract. 2013;124(1-2):47-53. doi: 10.1159/000355694. Epub 2013 Oct 15.

PMID:
24135465
37.

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.

38.

Cardiovascular events and mortality in chronic kidney disease (stages I-IV).

Quiroga B, Verdalles Ú, Reque J, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(4):539-45. doi: 10.3265/Nefrologia.pre2013.May.11895. English, Spanish.

39.

Hyporeninaemic hypoaldosteronism associated with membranous nephropathy: new hypotheses with regard to sodium retention in patients with proteinuria.

Quiroga B, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(3):428-9. doi: 10.3265/Nefrologia.pre2013.Mar.11841. English, Spanish. No abstract available.

40.

Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD).

Verdalles U, de Vinuesa SG, Goicoechea M, Quiroga B, Reque J, Panizo N, Arroyo D, Luño J.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv31-5. doi: 10.1093/ndt/gfs420.

PMID:
23258808
41.

Hypertension and cardiovascular risk in chronic kidney disease.

Luño J, Iturbe BR, Zoccali C.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv1. doi: 10.1093/ndt/gfs553. No abstract available.

PMID:
23258803
42.

[Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease].

Yuste C, García De Vinuesa S, Goicoechea M, Barraca D, Panizo N, Quiroga B, Luño J.

Med Clin (Barc). 2013 Oct 19;141(8):338-42. doi: 10.1016/j.medcli.2012.07.026. Epub 2012 Nov 23. Spanish.

PMID:
23182534
43.

Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: results from years 2009-2010.

Pérez-García R, Palomares-Sancho I, Merello-Godino JI, Aljama-García P, Bustamante-Bustamante J, Luño J, Maduell-Canals F, Martín-de Francisco AL, Martín-Malo A, Mirapeix-i-Vicens E, Molina-Núñez M, Praga-Terente M, Tetta C, Marcelli D; Grupo ORD (Optimizando Resultados de Diálisis).

Nefrologia. 2012;32(6):743-53. doi: 10.3265/Nefrologia.pre2012.Jul.11549. English, Spanish.

44.

High-sensitivity troponin T levels in kidney transplant recipients.

Arroyo D, Quiroga B, Panizo N, Rodríguez-Ferrero M, Macías N, Reque J, Anaya F, Luño J.

Transplant Proc. 2012 Nov;44(9):2545-7. doi: 10.1016/j.transproceed.2012.09.073.

PMID:
23146449
45.

Infective endocarditis on a percutaneous prosthetic aortic valve with associated glomerulopathy due to Granulicatella adjacens.

Quiroga B, Arroyo D, Verde E, Eworo A, Luño J.

Braz J Infect Dis. 2012 Nov-Dec;16(6):601-2. doi: 10.1016/j.bjid.2012.07.011. Epub 2012 Nov 10. No abstract available.

46.

Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis.

Quiroga B, Verde E, Abad S, Vega A, Goicoechea M, Reque J, López-Gómez JM, Luño J.

J Surg Res. 2013 Mar;180(1):51-5. doi: 10.1016/j.jss.2012.10.008. Epub 2012 Oct 29.

PMID:
23122519
47.

Hypercalcemia as a side effect of potassium binding agents.

Arroyo D, Panizo N, García de Vinuesa S, Goicoechea M, Verdalles U, Luño J.

Nefrologia. 2012;32(5):655-8. doi: 10.3265/Nefrologia.pre2012.Jun.11500. English, Spanish.

48.

The non-casual relation between eosinophilia and thrombotic microangiopathy.

Yuste C, Quiroga B, Verde E, Barraca D, Reque JE, Perez de Jose A, Luño J.

Transfus Apher Sci. 2012 Dec;47(3):365-7. doi: 10.1016/j.transci.2012.07.021. Epub 2012 Sep 17.

PMID:
22995791
49.

Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.

Fernandez Juarez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Cachofeiro V, Nieto J, Fernández Vega F, Tato A, Gutierrez E; PRONEDI Study Group.

Am J Kidney Dis. 2013 Feb;61(2):211-8. doi: 10.1053/j.ajkd.2012.07.011. Epub 2012 Aug 29.

PMID:
22939518
50.

Calciphylaxis in end-stage renal disease patients.

Verdalles U, García de Vinuesa S, Luño J.

Nephrol Dial Transplant. 2012 Sep;27(9):3663; author reply 3663-4. doi: 10.1093/ndt/gfs271. Epub 2012 Jul 17. No abstract available.

PMID:
22805222

Supplemental Content

Support Center